Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Cécile Vicier"'
Autor:
Guillaume Berton, Cécile Vicier, Marie-Anne Hospital, Colombe Saillard, Yosr Hicheri, Valerio Maisano, Ferdinand Villetard, Camille Rouzaud, Evelyne D’incan Corda, Jerome Rey, Bilal Mohty, Aude Charbonnier, Aurelien Proux, Norbert Vey, Anthony Goncalves, Sylvain Garciaz
Publikováno v:
HemaSphere, Vol 7, p e4520163 (2023)
Externí odkaz:
https://doaj.org/article/301143d94eb6467fa8b3cb884f0b6126
Autor:
Renaud Sabatier, Cécile Vicier, Séverine Garnier, Arnaud Guille, Nadine Carbuccia, Nicolas Isambert, Florence Dalenc, Marie Robert, Christelle Levy, Jihane Pakradouni, José Adelaïde, Max Chaffanet, Patrick Sfumato, Emilie Mamessier, François Bertucci, Anthony Goncalves
Publikováno v:
Molecular Oncology, Vol 16, Iss 10, Pp 2057-2070 (2022)
The phosphatidylinositol‐3‐kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway is frequently activated in HER2‐negative breast cancer and may play a role in taxane resistance. The phase IB/II TAKTIC trial (NCT01980277) has shown that
Externí odkaz:
https://doaj.org/article/703ca5faef324c5b808393f820024f09
Autor:
Roxane Mari, Mathilde Guerin, Cécile Vicier, Jochen Walz, Nathalie Bonnet, Géraldine Pignot, Gwenaelle Gravis
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundImmune checkpoint inhibitors deeply modified metastatic renal cell carcinoma’s management, and confront us to adverse events that we were not used to with conventional anti-cancer therapies. We report the case of a patient who received ni
Externí odkaz:
https://doaj.org/article/a97d1be667554866b1ad2ae0a550489b
Autor:
François Bertucci, Anthony Gonçalves, Arnaud Guille, José Adelaïde, Séverine Garnier, Nadine Carbuccia, Emilien Billon, Pascal Finetti, Patrick Sfumato, Audrey Monneur, Christophe Pécheux, Martin Khran, Serge Brunelle, Lenaïg Mescam, Jeanne Thomassin-Piana, Flora Poizat, Emmanuelle Charafe-Jauffret, Olivier Turrini, Eric Lambaudie, Magali Provansal, Jean-Marc Extra, Anne Madroszyk, Marine Gilabert, Renaud Sabatier, Cécile Vicier, Emilie Mamessier, Christian Chabannon, Jihane Pakradouni, Patrice Viens, Fabrice André, Gwenaelle Gravis, Cornel Popovici, Daniel Birnbaum, Max Chaffanet
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-20 (2021)
Abstract Background The benefit of precision medicine based on relatively limited gene sets and often-archived samples remains unproven. PERMED-01 (NCT02342158) was a prospective monocentric clinical trial assessing, in adults with advanced solid can
Externí odkaz:
https://doaj.org/article/685cee8dc4e4477fb464978bcebb91ff
Autor:
Emilien Billon, Brice Chanez, Philippe Rochigneux, Laurence Albiges, Cécile Vicier, Géraldine Pignot, Jochen Walz, Anne-Sophie Chretien, Gwenaelle Gravis, Daniel Olive
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The development of immune checkpoint inhibitors (ICI) has dramatically changed the landscape of therapies for metastatic renal cell carcinoma. However, many patients do not benefit from such therapy and prognostic or predictive validated biomarker va
Externí odkaz:
https://doaj.org/article/b21acc5c3f714dffb9b1185982a61475
Autor:
William Jacot, Amélie Lusque, Cécile Vicier, Audrey Mailliez, Thibault de La Motte Rouge, Luc Cabel, Christelle Levy, Anne Patsouris, Isabelle Desmoulins, Lionel Uwer, Jean-Christophe Thery, Mathieu Robain, Olivier Caron, Olivier Tredan, Thomas Filleron, Jean-Sébastien Frenel, Suzette Delaloge
Publikováno v:
British Journal of Cancer. 127:1963-1973
The efficacy and added benefit of platinum-based chemotherapy (PtCT) for metastatic breast cancer (MBC) remain unclear in patients with and without germline BRCA1 or BRCA2 mutations (gBRCA1/2m and gBRCA1/2wt, respectively).We selected from the French
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial
Autor:
Emilien Billon, Gwenaelle Gravis, Arnaud Guille, Nadine Carbuccia, Jose Adelaide, Séverine Garnier, Pascal Finetti, Emilie Denicolaï, Patrick Sfumato, Serge Brunelle, Jeanne Thomassin-Piana, Géraldine Pignot, Jochen Walz, Christian Chabannon, Jihane Pakradouni, Renaud Sabatier, Cécile Vicier, Cornel Popovici, Emilie Mamessier, Anthony Gonçalves, Daniel Birnbaum, Max Chaffanet, François Bertucci
Publikováno v:
Cancers; Volume 14; Issue 9; Pages: 2275
Cancers
Cancers, 2022, 14 (9), ⟨10.3390/cancers14092275⟩
Cancers
Cancers, 2022, 14 (9), ⟨10.3390/cancers14092275⟩
Simple Summary The goal of precision medicine is to deliver therapy matched to a relevant actionable genetic alteration (AGA) identified in the tumor. Few data are available regarding precision medicine in advanced urological cancers (AUC), the progn
Autor:
Zoé Guillaume, Emeline Colomba, Jonathan Thouvenin, Carolina Saldana, Luca Campedel, Clément Dumont, Brigitte Laguerre, Denis Maillet, Cécile Vicier, Frédéric Rolland, Delphine Borchiellini, Philippe Barthelemy, Laurence Albiges, Edouard Auclin, Matthieu Roulleaux Dugage, Stéphane Oudard, Constance Thibault
Publikováno v:
Cancers; Volume 14; Issue 7; Pages: 1678
Collecting duct carcinoma (CDC) and renal medullary carcinoma (RMC) are two rare subtypes of kidney cancer with a poor prognosis in the metastatic setting. Beyond first-line treatment, there are no standard-of-care therapies. This retrospective study
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, 2022, 109 (2), pp.216-225. ⟨10.1016/j.bulcan.2021.12.009⟩
Bulletin du Cancer, 2022, 109 (2), pp.216-225. ⟨10.1016/j.bulcan.2021.12.009⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f18bd3c68b7f2bea6bf7ed60098c3146
https://hal.science/hal-03622806
https://hal.science/hal-03622806
Publikováno v:
Bulletin du cancer. 109(2)
Overall, 2021 was marked by the confirmation of the major interest of cell cycle inhibitors for hormone receptor (HR) positive/human epidermal growth factor receptor 2 (HER2) negative advanced breast cancers with very high overall survival data excee